Modeling the efficacy of trastuzumab-DM1, an antibody drug conjugate, in mice

Author： Jumbe Nelson   Xin Yan   Leipold Douglas   Crocker Lisa   Dugger Debra   Mai Elaine   Sliwkowski Mark   Fielder Paul   Tibbitts Jay  

Publisher： Springer Publishing Company

ISSN： 1567-567X

Source： Journal of Pharmacokinetics and Pharmacodynamics, Vol.37, Iss.3, 2010-06, pp. : 221-242

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antibody-Drug Conjugate Targets

By  

Current Cancer Drug Targets, Vol. 9, Iss. 8, 2009-12 ,pp. : 982-1004

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Interaction Potential of Trastuzumab Emtansine (T-DM1) Combined with Pertuzumab in Patients With HER2-Positive Metastatic Breast Cancer

By  

Current Drug Metabolism, Vol. 13, Iss. 7, 2012-09 ,pp. : 911-922

Bentham Science Publishers

Access to resources Recommend Favorite

Non-Clinical Disposition and Metabolism of DM1, a Component of Trastuzumab Emtansine (T-DM1), in Sprague Dawley Rats

By  

Drug Metabolism Letters, Vol. 9, Iss. 2, 2015-08 ,pp. : 119-131

Bentham Science Publishers

Access to resources Recommend Favorite

Computational Approaches in Antibody-drug Conjugate Optimization for Targeted Cancer Therapy

By  

Current Topics in Medicinal Chemistry, Vol. 18, Iss. 13, 2018-05 ,pp. : 1091-1109

Bentham Science Publishers

Access to resources Recommend Favorite

Catabolic Fate and Pharmacokinetic Characterization of Trastuzumab Emtansine (T-DM1): an Emphasis on Preclinical and Clinical Catabolism

By  

Current Drug Metabolism, Vol. 13, Iss. 7, 2012-09 ,pp. : 901-910

Bentham Science Publishers

Access to resources Recommend Favorite